pentamidine has been researched along with Antibody Deficiency Syndrome in 10 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinical features of 49 episodes of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome were compared with those of 39 episodes in patients with other immunosuppressive diseases." | 1.27 | Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. ( Hiemenz, JW; Honig, C; Kovacs, JA; Lane, HC; Longo, DL; Macher, AM; Murray, HW; Shelhamer, J; Stover, D; Urmacher, C, 1984) |
| "A sever Pneumocystis carinii pneumonitis developed, but was successfully treated with pentamidine, sulfametoxazole with trimetoprim and transfer factor." | 1.26 | Indication of primary immune deficiency in Fanconi's anemia. ( Hertz, H; Lundsteen, C; Pedersen, FK; Platz, P; Thomsen, M, 1977) |
| "There are two types of Pneumocystis carinii pneumonia." | 1.26 | [Current aspects of differentiation and treatment of pneumocystis carinii pneumonia (author's transl)]. ( Ivády, G, 1976) |
| "Analysis of 194 patients with confirmed Pneumocystis carinii pneumonia in the United States over a 3-year period revealed that P." | 1.26 | Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features. ( Krogstad, DJ; Perl, DP; Rawson, PG; Schultz, MG; Walzer, PD, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kovacs, JA | 1 |
| Hiemenz, JW | 1 |
| Macher, AM | 1 |
| Stover, D | 1 |
| Murray, HW | 1 |
| Shelhamer, J | 1 |
| Lane, HC | 1 |
| Urmacher, C | 1 |
| Honig, C | 1 |
| Longo, DL | 1 |
| Hughes, WT | 1 |
| Roig Cutillas, J | 1 |
| de Gracia Roldán, J | 1 |
| Ruiz Manzano, J | 1 |
| Martínez Martínez, M | 1 |
| Bernardo Turmo, L | 1 |
| Morera Prat, J | 1 |
| Pedersen, FK | 1 |
| Hertz, H | 1 |
| Lundsteen, C | 1 |
| Platz, P | 1 |
| Thomsen, M | 1 |
| Geelhoed, GW | 2 |
| Hubbard, SB | 1 |
| Powell, RD | 1 |
| Doppman, JL | 1 |
| DeVita, VT | 2 |
| Ivády, G | 1 |
| Goodell, B | 1 |
| Hubbard, S | 1 |
| Young, RC | 1 |
| Walzer, PD | 1 |
| Perl, DP | 1 |
| Krogstad, DJ | 1 |
| Rawson, PG | 1 |
| Schultz, MG | 1 |
| Kautz-Freimuth, S | 1 |
| Smit, MJ | 1 |
| De Groot, R | 1 |
| Van Dongen, JJ | 1 |
| Van der Voort, E | 1 |
| Neijens, HJ | 1 |
| Whitfield, LR | 1 |
1 review available for pentamidine and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Pneumocystis carinii pneumonitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibodies; Child; Drug Combinations; Humans; Immunologic | 1984 |
9 other studies available for pentamidine and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Child; Drug Combinations; Drug Eruption | 1984 |
[Pneumocystis carinii pneumonia in a previously healthy patient].
Topics: Aged; Drug Combinations; Humans; Hypoglycemia; Immunologic Deficiency Syndromes; Male; Pentamidine; | 1984 |
Indication of primary immune deficiency in Fanconi's anemia.
Topics: Abnormalities, Multiple; Adrenal Cortex Hormones; Androgens; Anemia, Aplastic; Child; Chromosome Abe | 1977 |
Clinical characteristics of Pneumocystis carinii pneumonia.
Topics: Humans; Immunologic Deficiency Syndromes; Neoplasms; Pentamidine; Pneumonia, Pneumocystis | 1979 |
[Current aspects of differentiation and treatment of pneumocystis carinii pneumonia (author's transl)].
Topics: Age Factors; Dihydroergotoxine; Humans; Immunologic Deficiency Syndromes; Infant; Pentamidine; Pneum | 1976 |
Pneumocystis pneumonia in patients with cancer: clinical setting.
Topics: Adrenal Cortex Hormones; Diagnosis, Differential; Humans; Immunologic Deficiency Syndromes; Immunosu | 1976 |
Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features.
Topics: Adolescent; Adult; Age Factors; Aged; Black People; Child; Child, Preschool; Female; Humans; Immunol | 1976 |
[Pneumocystis carinii pneumonia: possible applications of pentamidine aerosol in hematology, oncology and transplantation medicine].
Topics: Aerosols; HIV Infections; Humans; Immunologic Deficiency Syndromes; Opportunistic Infections; Pentam | 1991 |
Trimetrexate efficacy and pharmacokinetics during treatment of refractory Pneumocystis carinii pneumonia in an infant with severe combined immunodeficiency disease.
Topics: Antifungal Agents; Drug Combinations; Glucuronates; Humans; Immunologic Deficiency Syndromes; Infant | 1990 |